A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics
Authors
Keywords
-
Journal
MedChemComm
Volume 8, Issue 3, Pages 516-533
Publisher
Royal Society of Chemistry (RSC)
Online
2017-01-26
DOI
10.1039/c6md00585c
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Vancomycin Derivative with a Pyrophosphate-Binding Group: A Strategy to Combat Vancomycin-Resistant Bacteria
- (2016) Venkateswarlu Yarlagadda et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Teicoplanin inhibits Ebola pseudovirus infection in cell culture
- (2016) Yizhuo Wang et al. ANTIVIRAL RESEARCH
- New Found Hope for Antibiotic Discovery: Lipid II Inhibitors
- (2016) Vivian Ng et al. CHEMISTRY-A EUROPEAN JOURNAL
- Overcoming β-lactam resistance in Gram-negative pathogens
- (2016) Karen Bush Future Medicinal Chemistry
- Antibiotics in the clinical pipeline at the end of 2015
- (2016) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
- (2016) Jürgen Brem et al. Nature Communications
- β-Lactams and β-Lactamase Inhibitors: An Overview
- (2016) Karen Bush et al. Cold Spring Harbor Perspectives in Medicine
- Intracellular activity of a membrane-active glycopeptide antibiotic against meticillin-resistant Staphylococcus aureus infection
- (2016) Venkateswarlu Yarlagadda et al. Journal of Global Antimicrobial Resistance
- Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria
- (2015) Venkateswarlu Yarlagadda et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- In VitroAntimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
- (2015) Naoki Kohira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria
- (2015) Venkateswarlu Yarlagadda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Oritavancin: A Long-Half-Life Lipoglycopeptide
- (2015) Louis D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455
- (2015) Venkateswarlu Yarlagadda et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vivo efficacy and pharmacological properties of a novel glycopeptide (YV4465) against vancomycin-intermediate Staphylococcus aureus
- (2015) Venkateswarlu Yarlagadda et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Membrane Active Small Molecules Show Selective Broad Spectrum Antibacterial Activity with No Detectable Resistance and Eradicate Biofilms
- (2015) Jiaul Hoque et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure Diversification of Vancomycin through Peptide-Catalyzed, Site-Selective Lipidation: A Catalysis-Based Approach To Combat Glycopeptide-Resistant Pathogens
- (2015) Sabesan Yoganathan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Surviving sepsis in the era of antibiotic resistance: Are there any alternative approaches to antibiotic therapy?
- (2015) Divakara S.S.M. Uppu et al. MICROBIAL PATHOGENESIS
- A new antibiotic kills pathogens without detectable resistance
- (2015) Losee L. Ling et al. NATURE
- The β-Lactams Strike Back: Ceftazidime-Avibactam
- (2015) Evan J. Zasowski et al. PHARMACOTHERAPY
- Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria
- (2015) Venkateswarlu Yarlagadda et al. ACS Infectious Diseases
- Lysine-Based Small Molecules That Disrupt Biofilms and Kill both Actively Growing Planktonic and Nondividing Stationary Phase Bacteria
- (2015) Mohini M. Konai et al. ACS Infectious Diseases
- Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
- (2015) Helen I. Zgurskaya et al. ACS Infectious Diseases
- Aryl-Alkyl-Lysines: Agents That Kill Planktonic Cells, Persister Cells, Biofilms of MRSA and Protect Mice from Skin-Infection
- (2015) Chandradhish Ghosh et al. PLoS One
- Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F
- (2014) Martina Hrast et al. BIOORGANIC CHEMISTRY
- Tackling vancomycin-resistant bacteria with ‘lipophilic–vancomycin–carbohydrate conjugates’
- (2014) Venkateswarlu Yarlagadda et al. JOURNAL OF ANTIBIOTICS
- Glycopeptide antibiotics: Back to the future
- (2014) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Membrane Active Vancomycin Analogues: A Strategy to Combat Bacterial Resistance
- (2014) Venkateswarlu Yarlagadda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Total Synthesis of [Ψ[C(═NH)NH]Tpg4]Vancomycin and its (4-Chlorobiphenyl)methyl Derivative: Impact of Peripheral Modifications on Vancomycin Analogues Redesigned for Dual d-Ala-d-Ala and d-Ala-d-Lac Binding
- (2014) Akinori Okano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis
- (2014) L.-T. Sham et al. SCIENCE
- Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii
- (2013) C. Rumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Kinetic mechanism and inhibition ofMycobacterium tuberculosisd-alanine:d-alanine ligase by the antibioticd-cycloserine
- (2013) Gareth A. Prosser et al. FEBS Journal
- Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria
- (2013) J. R. Morones-Ramirez et al. Science Translational Medicine
- Redesign of Glycopeptide Antibiotics: Back to the Future
- (2012) Robert C. James et al. ACS Chemical Biology
- In VitroActivity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens
- (2012) Michael Hornsey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin: Mechanism of Action
- (2012) George G. Zhanel et al. CLINICAL INFECTIOUS DISEASES
- Teicoplanin therapy leading to a significant decrease in viral load in a patient with chronic hepatitis C
- (2012) A. Maieron et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- d-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium
- (2011) François Lebreton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent advances in the synthesis of new glycopeptide antibiotics
- (2011) Polly-Anna Ashford et al. CHEMICAL SOCIETY REVIEWS
- New Delhi Metallo- -Lactamase and Multidrug Resistance: A Global SOS?
- (2011) R. A. Bonomo CLINICAL INFECTIOUS DISEASES
- In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii
- (2011) D. W. Wareham et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Redesigned Vancomycin Engineered for Duald-Ala-d-Ala andd-Ala-d-Lac Binding Exhibits Potent Antimicrobial Activity Against Vancomycin-Resistant Bacteria
- (2011) Jian Xie et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Total Synthesis of [Ψ[C(═S)NH]Tpg4]Vancomycin Aglycon, [Ψ[C(═NH)NH]Tpg4]Vancomycin Aglycon, and Related Key Compounds: Reengineering Vancomycin for Dual d-Ala-d-Ala and d-Ala-d-Lac Binding
- (2011) Jian Xie et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- vanM, a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium
- (2010) X. Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli
- (2010) M. G. P. Page et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- Oritavancin: a novel lipoglycopeptide active against Gram-positive pathogens including multiresistant strains
- (2010) Emilio Bouza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria
- (2010) Daria Nicolosi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Discovery of a Novel Series of Semisynthetic Vancomycin Derivatives Effective against Vancomycin-Resistant Bacteria
- (2010) Yuki Nakama et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis Strains
- (2009) K. L. LaPlante et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis
- (2009) S. Svetitsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
- (2009) F. F. Arhin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Beta-lactam antibiotics: from antibiosis to resistance and bacteriology
- (2009) KOK-FAI KONG et al. APMIS
- Telavancin: A Novel Lipoglycopeptide
- (2009) Louis D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Exploring the Positional Attachment of Glycopeptide/β-lactam Heterodimers
- (2009) Daniel D Long et al. JOURNAL OF ANTIBIOTICS
- Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters
- (2009) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
- (2009) Gary J. Patti et al. JOURNAL OF MOLECULAR BIOLOGY
- Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel D-Ala-D-Ser Gene Cluster, vanL
- (2008) D. A. Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Vancomycin−Nisin(1−12) Hybrid Restores Activity against Vancomycin Resistant Enterococci†
- (2008) Christopher J. Arnusch et al. BIOCHEMISTRY
- Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic
- (2008) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Dalbavancin
- (2008) Vanessa R Anderson et al. DRUGS
- Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs
- (2008) Yasushi Nitanai et al. JOURNAL OF MOLECULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started